| Cardiovascular Risk Management |
1 |
0.96 |
| Hypertension |
0 |
0.9 |
| Coronary Artery Disease (CAD) |
0 |
0.85 |
| Heart |
0 |
0.8 |
| Health Care Reform |
0 |
0.75 |
| Outpatient Clinic |
0 |
0.31 |
| Genomic Medicine |
0 |
0.5 |
| Cardiovascular disease |
0 |
0.22 |
| Primary Care |
0 |
0.22 |
| Myocardial Infarction (MI) |
0 |
0.17 |
| Care and Maintenance of Vision |
0 |
0.14 |
| California |
0 |
0.13 |
| Clinical Guidelines |
0 |
0.13 |
| Europe |
0 |
0.13 |
| Preventive Screening |
0 |
0.13 |
| Blood |
0 |
0.09 |
| Calcium |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| Lipids Management |
0 |
0.09 |
| Massachusetts |
0 |
0.09 |
| Obesity |
0 |
0.09 |
| Osteoarthritis |
0 |
0.09 |
| UK Site Content |
0 |
0.09 |
| Atherosclerosis |
0 |
0.08 |
| Cerebrovascular Accident |
0 |
0.08 |
| Acute Myocardial Infarction (MI) |
0 |
0.06 |
| Thromboembolism |
0 |
0.06 |
| A-Scan Biometry |
0 |
0.04 |
| Artery |
0 |
0.04 |
| Biologic Therapy |
0 |
0.04 |
| Biomarker |
0 |
0.04 |
| Cataract |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Disease Management |
0 |
0.04 |
| Epidemiology |
0 |
0.04 |
| Fellowship |
0 |
0.04 |
| Infarction |
0 |
0.04 |
| Insulin Resistance |
0 |
0.04 |
| Ischemic Stroke |
0 |
0.04 |
| Lung |
0 |
0.04 |
| Precision Medicine |
0 |
0.04 |
| Professional Development |
0 |
0.04 |
| Scan |
0 |
0.04 |
| Statins |
0 |
0.04 |
| Stress |
0 |
0.04 |
| Telehealth and Telemedicine |
0 |
0.04 |